Challenges and opportunities in using residual newborn screening samples for translational research
Subtitle: workshop summary
By: Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Contributors: Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health
Publisher: National Academies Press
Published: 2010
Place of publication: Washington, D.C
Language: eng
Number of pages: 67
ISBN-13: 9780309159548
Subjects: Moral and ethical aspects; Newborn infants; Diseases; Diagnosis; Neonatology; Research
Description: "Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
Notes: Includes bibliographical references.

Also available online.
Table of contents: title: Newborn screening as a public health program; title: Uses of residual newborn screening samples in research; title: Concerns about the use of residual newborn screening samples; title: Review and consent in the use of residual newborn screening samples; title: Parental and public education; title: Workshop overview and wrap-up.